KitoTech Medical

Seattle, United States

KitoTech Medical is a medical device company developing and commercializing products for wound closure and wound care.

$2.0M raised

Dec 2021

Series B

Biotechnology Health Care Manufacturing Medical Device

Top Investors

Keiretsu Capital Grand Angels Keiretsu Forum Thynk Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about KitoTech Medical

How much funding has KitoTech Medical raised?

KitoTech Medical has raised $2.0M in total funding. The most recent round was Series B. The last funding was announced in December 2021.

Who are KitoTech Medical's investors?

KitoTech Medical's investors include Keiretsu Capital, Grand Angels, Keiretsu Forum, Thynk Capital.

Where is KitoTech Medical headquartered?

KitoTech Medical is headquartered in Seattle, United States.

What does KitoTech Medical do?

KitoTech Medical is a medical device company developing and commercializing products for wound closure and wound care.

What stage is KitoTech Medical at?

KitoTech Medical is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 6, 2021.

MLA

"KitoTech Medical — Funding & Investors." VCBacked, December 6, 2021, https://www.vcbacked.co/company/kitotech-medical. Accessed July 3, 2026.

APA

VCBacked. (2021). KitoTech Medical — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/kitotech-medical

Wikipedia (cite web)

{{cite web |title=KitoTech Medical — Funding & Investors |url=https://www.vcbacked.co/company/kitotech-medical |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 6, 2021.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K